Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01673737
Title A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sanofi
Indications
Therapies
Age Groups: adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Investigational Site Number 840001 Boston Massachusetts 02114 United States Details
Investigational Site Number 840101 Boston Massachusetts 02115 United States Details
Investigational Site Number 840002 Houston Texas 77054 United States Details
Investigational Site Number 124001 Toronto M5G 2M9 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field